ProCE Banner Activity

Considerations in Selecting Therapy for Previously Treated CLL

Slideset

Download this slideset from a live symposium at ASH 2023 for expert perspectives on best practices in treating patients with relapsed/refractory CLL.

Released: December 06, 2023

Expiration: December 05, 2024

Share

Provided by

Provided by the National Comprehensive Cancer Network in collaboration with Clinical Care Options, LLC

ProCE Banner

Supporters

Supported by educational grants from AstraZeneca, BeiGene and Lilly.

AstraZeneca

BeiGene

Lilly

Partners

Clinical Care Options, LLC

ProCE Banner